1. Sustained MRD negativity predicts outcomes post transplant in myeloma: a real world study
Presented at EHA2018
Michael Austin
Haematology SpR, South West London Deanery; 2018

2. Special thanks to

3. The project
MRD negativity at 3 months post autologous stem cell transplant (ASCT) is known to be a good prognostic marker in myeloma
Does sustained MRD negativity at 1 year post-ASCT predict outcomes as well?
Retrospective study
368 consecutive ASCT
The Royal Marsden from 2011 to 2015
MRD data collected at 3 and 12 months post-ASCT

4. Results
Sustained MRD negativity between 3 and 12 months post transplant predicts excellent outcomes
1st transplant
2nd transplant

5. The poster

6. Acknowledgments The patients The UK Myeloma Forum and The Binding Site
The myeloma and transplant teams at RMH

7. Thank you